Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety Assessment of Azyter eye drops (T1225) in patients with blepharitis
2009-017388-41Phase 2Active
- Sponsor
- Laboratoires Théa
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in blepharitis comparing Azyter eye drops with Placebo eye drops (2 arms). Primary endpoint: Change in global ocular discomfort (VAS) from baseline to Day 63. Started Dec 2009; status: active.
02
Drugs
azithromycin
03
Conditions
blepharitis
Beyond the preview
Go deeper on 2009-017388-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017388-41.